publicações selecionadas
-
documento
- Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma 2022
- Understanding the cellular metabolic reprogramming associated with bevacizumab therapy in glioblastoma 2017
- HER receptors are important theranostic biomarkers on cervical cancer: blocking glucose metabolism enhances the therapeutic effect of HER inhibitors 2016
- Targeting lactate transport suppresses in vivo breast tumor growth 2015
- Monocarboxylate Transporter 1 (MCT1) expression at hypoxic conditions in glioblastomas: functional role and regulation 2015